[29V09-am] 薬物治療（基礎）②/その他

[29V09-am09S] Reversible keap1 inhibitor ameliorates renal function and pathology in mouse model of alport syndrome

○Shota Kaseda^1,2, Yuya Sannomiya¹, Jun Kuwazuru¹, Sayaka Ogi³, Ryoko Sasaki¹, Hidetoshi Sunamoto³, Hirohiko Fukiya³, Hayato Nishiyama³, Misato Kamura^1,2, Saki Niinou¹, Jun Horizono¹, Yuimi Koyama¹, Mary Ann Suico¹, Kazuhiro Onuma³, Futoshi Nara³, Tsuyoshi Shuto¹, Hirofumi Kai¹ (1. Grad. Sch. Pharm Sci., Kumamoto Univ., 2. HIGO program., Kumamoto Univ., 3. Pharm. Res. Lab., UBE Inds. Ltd.)